With volumes of pipeline and clinical trial data at our fingertips, artificial intelligence (AI) can help pharmaceutical companies make better decisions about how to grow organically and inorganically. But many companies still use broad historical benchmarks and basic competitive intelligence tools to identify attractive market opportunities and external innovation. With our partners at Intelligencia, we’ll explore applications of AI in pipeline and portfolio strategy to maximize growth potential and capital efficiency.
In this webinar, we’ll cover how to:
- Apply AI and machine learning tools in the context of competitive intelligence and market scanning
- More accurately anticipate future competitive environments across diseases
- Use the power of analytics to make better bets on external innovation
Please join us in a discussion with Intelligencia’s chief customer officer, Rena Rosenberg.
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.